BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37024811)

  • 1. Herpesvirus immunology in solid organ transplant recipients - liver transplant study (HISTORY): a retrospective and prospective observational cohort study.
    Suarez-Zdunek MA; Saini SK; Pedersen CR; Hamm SR; Hald A; Rasmussen A; Hillingsø JG; Hadrup SR; Nielsen SD
    BMC Infect Dis; 2023 Apr; 23(1):214. PubMed ID: 37024811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
    Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
    Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
    Martin-Gandul C; Stampf S; Héquet D; Mueller NJ; Cusini A; van Delden C; Khanna N; Boggian K; Hirzel C; Soccal P; Hirsch HH; Pascual M; Meylan P; Manuel O;
    Am J Transplant; 2017 Jul; 17(7):1813-1822. PubMed ID: 28039960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function.
    Møller DL; Sørensen SS; Rezahosseini O; Rasmussen DB; Arentoft NS; Loft JA; Perch M; Gustafsson F; Lundgren J; Scheike T; Knudsen JD; Ostrowski SR; Rasmussen A; Nielsen SD
    Front Immunol; 2023; 14():1183703. PubMed ID: 37465673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients.
    Crouch A; Le M; Rogers C; Shao S; Kotton C
    Transpl Infect Dis; 2021 Oct; 23(5):e13711. PubMed ID: 34379876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-Parameter FluoroSpot Assay Reveals That the Varicella Zoster Virus Elicits a Robust Memory T Cell IL-10 Response throughout Childhood.
    Nilsson A; Höbinger A; Jahnmatz P; Tiselius E; Laestadius Å; Melén E; Björkander S; Saghafian-Hedengren S
    J Virol; 2022 Nov; 96(22):e0131022. PubMed ID: 36314824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
    Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
    J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection after liver transplantation: current concepts and challenges.
    Razonable RR
    World J Gastroenterol; 2008 Aug; 14(31):4849-60. PubMed ID: 18756591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients.
    Getsuwan S; Apiwattanakul N; Lertudomphonwanit C; Hongeng S; Boonsathorn S; Manuyakorn W; Tanpowpong P; Anurathapan U; Tangnararatchakit K; Treepongkaruna S
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
    Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
    Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
    J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort study.
    Hamm SR; Saini SK; Hald A; Vaaben AV; Pedersen NW; Suarez-Zdunek MA; Harboe ZB; Bruunsgaard H; Johansen IS; Larsen CS; Bistrup C; Birn H; Sørensen SS; Hadrup SR; Nielsen SD
    BMC Infect Dis; 2023 Oct; 23(1):687. PubMed ID: 37845608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
    Huang JG; Tan MYQ; Quak SH; Aw MM
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29071779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.
    Hakimi Z; Aballéa S; Ferchichi S; Scharn M; Odeyemi IA; Toumi M; Saliba F
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28599091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial.
    Smith C; Beagley L; Rehan S; Neller MA; Crooks P; Solomon M; Holmes-Liew CL; Holmes M; McKenzie SC; Hopkins P; Campbell S; Francis RS; Chambers DC; Khanna R
    Clin Infect Dis; 2019 Feb; 68(4):632-640. PubMed ID: 29982441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.